🌿 WellnessTrading
Will microdosing GLP-1 drugs gain widespread use for PCOS management by end of 2026?
Current Probability
55%
261 days left
$9,870 volume
55% Yes45% No
About This Market
Tracks whether GLP-1 receptor agonists become commonly recommended for PCOS management.
Resolution Criteria
At least two major health systems or professional organizations recommend GLP-1 for PCOS management.
Closes: Thursday, December 31, 2026
Important Disclaimer
This prediction market uses play-money beta credits with no cash value. Odds reflect crowd sentiment, not certainty. This is not financial, medical, or investment advice. Resolution is determined solely by the pre-stated criteria and source listed above.
Trade
This is a play-money prediction market using beta credits with no cash value. Not financial, medical, or investment advice. Trade responsibly.
Market Stats
Total Volume$9,870
Liquidity100
CreatedFeb 25